PRESENTATION

H1 FY2026 — Results presentation

H1 FY2026PDF · 73 pages6.0 MB
Unaudited
Interim Results
for the six months ended 31 December 2025

-- 1 of 73 --

2
Performance overview
Normalised
profit
+24%
to R8 891m
Headline
earnings
+29%
to R5 692m
Normalised
headline earnings
+27%
to R5 745m
New
business
+12%
to R14 026m

-- 2 of 73 --

3
Two prominent disruptive forces over the period
Geopolitical rupture Proliferation of AI
Source: World Economic Forum Global Risks Report 2026; McKinsey and Co The State of AI in 2025

-- 3 of 73 --

4
Summary

-- 4 of 73 --

5
Key insights
Evolving the Vitality Shared-value model to deliver hyper-
personalised engagement and value through Vitality AI
1
2
3
Strong performance with continued delivery ahead of the
five-year growth corridor targets
Focused execution within each composite

-- 5 of 73 --

6
H1 FY26 performance
to R8 891m
+24%

-- 6 of 73 --

7
Strong operating profit growth
Health 2 128 +5%
Life 3 093 +15%
Invest 984 +1%
Insure 546 +34%
Bank 75 <-100%
Other SA1 -51 -80%
Discovery SA 6 775 +19%
VitalityHealth 1 186 +98%
VitalityLife 352 +8%
Ping An Health Insurance 573 +35%
VHI - Other -16 -89%
Vitality Network 176 -48%
Vitality AI2 -155 >+100%
Vitality 2 116 +41%
Normalised profit, ZARm
1 Includes Discovery Vitality
2 Includes Other Vitality central costs
0
1 000
2 000
3 000
4 000
5 000
6 000
7 000
8 000
9 000
10 000
H1 2003	
H1 2005	
H1 2007	
H1 2009
H1 2011	
H1 2013	
H1 2015	
H1 2017	
H1 2019	
H1 2021	
H1 2023	
H1 2025
13%
15-yr CAGR
15%
5-yr CAGR
to R8 891m
+24%
Normalised operating profit

-- 7 of 73 --

8
Solid new business
Health 5 454 +16% 811 +26%
Life 1 635 -1% | 16%*
Invest 1 961 +13% | 19%*
Insure 646 -2%
Bank 1 438 +31%
Vitality 246 -4%
Discovery SA 9 942 +10% 2 249 29%
VitalityHealth 1 440 +9%
VitalityLife 1 495 +36% | 35%*
Vitality Network 831 -14%
Ping An Health
Insurance 1 149 +6%
VHI - Other 487 +5%
Vitality 4 084 +16% 1 318 -8%
ZARm New business
Non-insurance
income
to R14 026m
+12%
New business
0
2 000
4 000
6 000
8 000
10 000
12 000
14 000
16 000
H1 2003	
H1 2005	
H1 2007	
H1 2009
H1 2011	
H1 2013	
H1 2015	
H1 2017	
H1 2019	
H1 2021	
H1 2023	
H1 2025
Sasolmed
*New business APE

-- 8 of 73 --

9
Continued client growth
SA Vitality excl. PAHI PAHI
to 6.5m
+7% to 11.2m
+15% to 34.1m
+17%
0
1
2
3
4
5
6
7
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Millions
0
2
4
6
8
10
12
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Millions
0
5
10
15
20
25
30
35
40
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Millions
Lives impacted

-- 9 of 73 --

10
Robust return on Group EV
17.3% Annualised return on EV
Significant improvement in VNB
Robust earnings from non-covered
businesses
Positive non-economic experience variances
across all businesses
Impact of economic assumption changes
partially offset by forex movements
R135 163m
R126 554m
R135 844m
a
b
c
d
Econ variance and
assumption changes
Opening EV
Non
-econ variances &
assumption changes
Closing EV
Operational EV
Forex
RDR unwind
VNB
Non
-covered businesses	
Finance, investment
returns & other
Capital & dividend changes

-- 10 of 73 --

11
Robust cash generation
71% Cash conversion ratio
Cash generated from in-force Cash uses: New business and tax Operating Cash Flow
H1 2024 H1 2025 H1 2026
-R3.7bn
New
business net
of external
funding
-R1.3bn
Tax
-R758m	-R792m
-R3.5bn	-R3.5bn
-R4.3bn	-R4.3bn -R5.0bn
H1 2024 H1 2025 H1 2026
Discovery
Health
Discovery
Life
Discovery
Invest
Vitality
Health
Insure
Vitality Life
R8.3bn
R7.6bn
R9.7bn
H1 2024 H1 2025 H1 2026
R4.6bn
R4.1bn
R3.2bn
Uncasted figures

-- 11 of 73 --

12
Group is well capitalised
1 Normalised for COVID-19 reserve impact, refer to Annexure A; 2 Capital Adequacy Ratio; 3 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission
Strong cash conversion Strongly capitalised FLR decreasing
Group cash conversion ratio1 Financial leverage ratio	Solvency cover
DHMS solvency
(unaudited)
Dec 25
Cover
Dec 24
Cover
Life 1.8x 1.8x
Insure 2.1x 2.0x
VH 1.7x 1.7x
VL 1.9x 2.0x
Bank2 1.1x 1.2x
PAHI3 3.1x 3.4x
32.6%
10%
15%
20%
25%
H1 FY23
FY23
H1 FY24
FY24
H1 FY25
FY25
H1 FY26
15.1%
10%
30%
50%
70%
90%
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
71%
31.0%

-- 12 of 73 --

13
Supportive below-the-line performance
R million
Actual Actual
%	H1 2026 H1 2025
Normalised profit from operations 8 891 7 188 24%
Finance charges excl. 1DP finance lease -838 -954
Investment income and fair value gains on financial instruments 236 260
1 DP finance lease impact -25 -44
Other forex (losses)/gains -13 13
Other -63 -126
Profit before tax 8 188 6 337 29%
Taxation -2 429 -1 845
Profit after tax 5 759 4 492 28%
Profit not attributable to ordinary shareholders -90 -102
Loss on derecognition of intangible assets 21 16
Other headline earnings adjustments 2 22
Headline earnings 5 692 4 428 29%
Amortisation of intangibles from business combinations 29 22
Restructuring costs - 36
Other normalised headline earnings adjustments 24 25
Normalised headline earnings 5 745 4 511 27%
Interim ordinary dividend
declaration of 111 cps
28% growth

-- 13 of 73 --

14
Delivery ahead of targets with confidence in achieving
targets for FY26 and the remainder of the planning cycle
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors and reflects the average expected over the time frame
*Spend on new includes Discovery Green, Vitality AI and VHI Other
Performance
Capital
allocation
Returns
Cash
conversion
ratio
(normalised history)
Normalised
profit growth
% spend
on new
Dividend
cover
FLR
Normalised
RoE
Expected FY26	H1 FY26	Targets
15-20%
RoE
15-20%
CAGR
c5%
Spend on new
10-20%
FLR
≤5x
Dividend cover
24%
15.1%
30-40% of
expected full
year dividend
at H1 FY26
3%*
Within
plan
Above
plan
Better
than plan
Within
plan
Within
plan
Within
plan
Scaled growth	Investment	Organic growth
-20%
0%
20%
40%
0%
10%
20%
30%
0%
20%
40%
0%
50%
100%
0%
10%
20%
30%
0
5
60-70%
Cash conversion
ratio
Illustrative ranges	CAGR 9%	CAGR 22%
8% 15%Average Average
Average 56%	60% Average
Average 22%	3%Average
4.6x 5.7xAverage Average
Average 13%Average 20%
FY
06
FY
15
FY
16
FY
24
FY
25
FY
29
H1
26
71%
17.4%

-- 14 of 73 --

15
3 Human-centric < AI-driven intelligence 4	Fragmented data < Quantified self
• 90% of insurers are deploying or evaluating AI – yet
only a small cohort is extracting material value.
• AI is enabling 50–75% faster processing and ~20% cost
savings in early adopters.
• > 70% of global insurance purchases have traditionally
been intermediary-led, yet up to 40% of broker activity
can now be automated or augmented by AI.
• ~ 97% of health data goes unused, with insight
concentrated around illness rather than daily behaviour.
• Digital health adoption accelerating as software, data
& analytics become fastest-growing healthcare
segments ~ 35% of adults in developed markets use
wearables.
• Sustained behaviour change proven (RAND study): 34–
40% activity uplift with Apple Watch and Vitality.
1 Actuarial dogma < Behavioural nature of risk 2	Generic approach < Predictive & personalised
• Traditional insurance assumes risk is fixed at entry despite
growing evidence that behaviour materially alters longevity.
• Engagement remains minimal, with traditional insurers averaging
~40 customer interactions over 20 years.
• Ageing populations, rising chronic disease and healthcare
inflation are materially compressing affordability.
• Standard treatment pathways are built for the “average patient”,
with failure rates of up to 40% due to biological variation.
• Predictive, personalised care improves adherence by ~42%,
increases engagement >50%, & reduces readmissions by ~35%.
• GLP-1 therapies now account for ~10% of employer claims, but
behaviour-linked pathways can reduce long-term cost trend.
Structural forces reshaping insurance industry – amplifying
advantage for models built on data and behaviour change
Sources: Swiss Re Institute (2025), Sigma No. 5/2025: Global economic and insurance outlook – Shifting sands; McKinsey & Company (2025), What to expect in US healthcare; Swiss Re Sigma (2025), historical data on real healthcare cost growth vs GDP; Mandalore Partners (2025), Major Insurtech
Trends: AI, Personalization & Automation; McKinsey Global Insurance AI Commentary (2024–2025); NBOA (2025), GLP-1 drugs now ~10% of employer annual claims; Deloitte (2024–2025), Digital Consumer Trends
AI is reshaping the industry’s economics and widening the gap
between intelligent, AI-native insurers extracting operating
leverage at scale and legacy players preserving traditional models.
Health is shifting from episodic measurement to continuous
self-management, making personal agency central to value
perception and product design in health and insurance.
Passive, one-off risk pricing models are structurally
exposed to rising claims & margin erosion, accelerating
the shift to dynamic, behaviour-driven models.
Healthcare is shifting from treating populations to
managing individual risk, increasing the need for
personalised behavioural intervention.

-- 15 of 73 --

16
Broad-based contribution in Discovery SA, with a strong
contribution from VitalityHealth in the Vitality composite
Discovery SA profit growth build-up Vitality profit growth build-up
39% 2%
9%
10%
-11%
-8%
41%
VitalityHealth
VitalityLife	
VHI
 - Other
PAHI
Vitality Network
Vitality AI
Vitality
2%
7%
2%
4%
4%
0.2%
19%
Discovery Health
Discovery Life
Discovery Invest	
Discovery Insure
Discovery Bank
Other
Discovery SA

-- 16 of 73 --

17
The architecture of the Vitality Shared-value model

-- 17 of 73 --

18
Shared value results in a structurally different value chain
that generates significant alpha
𝛼
OPTIMISED
RETENTION
SHARED-VALUE
INCENTIVES
+ + -BEHAVIOUR
CHANGE
DYNAMIC
PRICING x VOLUME
𝑒𝑥
𝑷𝒓𝒆𝒎𝒊𝒖𝒎
𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌
∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓
𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌 × ∆ 𝑪𝒍𝒂𝒊𝒎𝒔
∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓
∆ 𝑯𝒆𝒂𝒍𝒕𝒉𝒚 𝑳𝒊𝒗𝒆𝒔
∆ 𝑻𝒐𝒕𝒂𝒍 𝑳𝒊𝒗𝒆𝒔
∆ 𝑰𝒏𝒄𝒆𝒏𝒕𝒊𝒗𝒆
∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓

-- 18 of 73 --

19
VitalityLife is a leading UK life insurer driving superior
shared-value performance
47% lower lapses with
75% more healthy lives
after 20 years
Optimiser
policies experience
18% lower claims
24-53% more premium
per unit of risk
>5x price elasticity
results in large volume
from small prices changes
Average consumer value
uplift over first 3 years is
30-59% of premiums
𝑷𝒓𝒆𝒎𝒊𝒖𝒎
𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌
∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓
𝑼𝒏𝒊𝒕 𝒐𝒇 𝑹𝒊𝒔𝒌 × ∆ 𝑪𝒍𝒂𝒊𝒎𝒔
∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓
∆ 𝑯𝒆𝒂𝒍𝒕𝒉𝒚 𝑳𝒊𝒗𝒆𝒔
∆ 𝑻𝒐𝒕𝒂𝒍 𝑳𝒊𝒗𝒆𝒔
∆ 𝑰𝒏𝒄𝒆𝒏𝒕𝒊𝒗𝒆
∆ 𝑩𝒆𝒉𝒂𝒗𝒊𝒐𝒖𝒓
+39% +68% +17% -49% +35%
New business
value impact
𝛼 New business
value improvement
+110% ~ RF+9%
New business
value margin
𝑒𝑥 added to customers’ lives
+5 years
OPTIMISED
RETENTION
SHARED-VALUE
INCENTIVES
+ + -BEHAVIOUR
CHANGE
DYNAMIC
PRICING x VOLUME
Analysis results shown are derived from a portfolio-level analysis based on a defined cohort of shared-value business observed over a specified multi-year period

-- 19 of 73 --

20
Shared value delivering demonstrable alpha across the
businesses over the period
Cost per
benefit unit1
-17.7%
LONG-TERM BUSINESSES SHORT-TERM BUSINESSES
11.3%
Operating
margin
15.2%
Operating
margin
1%
Operating
margin
RF+9%
New business
IRR
RF+8%
New business
IRR
1 Contribution differential between Discovery Health Medical Scheme and the next seven competitors; 2 Gold and Diamond Vitality status members relative to non-engaged (Blue Vitality status)
MEDICAL SCHEME
OPTIMISED
RETENTION
SHARED-VALUE
INCENTIVES
+ + -BEHAVIOUR
CHANGE
DYNAMIC
PRICING x VOLUME
𝛼
𝑒𝑥 added to
customers’ lives
+5 years
added to engaged
customers’ lives2
+6 years Longer
investment terms
+3.4 years Lower claims on average
for Vitality members
-20%
Lower road fatality rates for
engaged members2
-74% Lower hospital admissions
for engaged members2
-16%

-- 20 of 73 --

21
OPTIMISED
RETENTION
SHARED-VALUE
INCENTIVES
+ + -BEHAVIOUR
CHANGE
DYNAMIC
PRICING x VOLUME
Shared value delivering demonstrable alpha across the
businesses over the period
𝛼
+82%
VNB improvement
+110%
New business value improvement
+48%
Profit margin increase
+124%
Margin increase
Analysis results shown are derived from a portfolio-level analysis based on a defined cohort of shared-value business observed over a specified multi-year period

-- 21 of 73 --

22
+19% +41%
H1 FY26 profit growth:

-- 22 of 73 --

23
Focused execution of the Vitality Shared-value model
within each composite
Proprietary
data
Dynamic
risk
assessment
Vitality.AI
recommender
Incentivised
engagement
Insurance
integration

-- 23 of 73 --

24
Discovery SA
Discovery Bank	
Discovery Insure	
Discovery Invest	
Discovery Life	
Discovery Health

-- 24 of 73 --

25
Green shoots emerging in the South African context
2023/4 Position 2025/Current
Energy 98% reduction in
loadshedding 290 days of loadshedding 7 days of loadshedding (2025)
Transport and logistics 22Mt increase in annual
freight railed 34% drop in rail volumes1 +15% increase in rail volumes
Crime and corruption Removal from the FATF
list
FATF Grey list
Deficient in 20/40 areas
SA removed from FATF grey
list
Economic growth Moderate but improving
GDP growth 2024: 0.5% 2025F: 1.2-1.6% | 2026P: 1.4-1.9%
Government bond
yields (10-year)
Bond yields benefited
from improved sentiment Jan 2025: 10.38% YTD: 8.10%
Inflation Inflation at a 21-year low 2024: 4.4% 2025: 3.2%
Exchange rate Currency stability with the
Rand appreciating End 2024: R18.71/$ YTD: R16.13/$
S&P credit rating First major rating
upgrade in over 16 years
Foreign currency: BB-
Local: BB
Foreign currency: BB
Local: BB+ (positive outlook)
1 226Mt in FY17/18, vs R149Mt FY22/23
Sources: South African Reserve Bank; Investing.com; StatsSA, National Treasury, International Monetary Fund

-- 25 of 73 --

26
Disciplined execution and delivery against targets
Discovery Bank	
Discovery Insure	
Discovery Invest	
Discovery Life	
Discovery Health
Leading financial services group in SA
which, through its fully Bank-integrated
composite and Vitality Shared-value model,
creates a unique shared-value customer-
centric composite
Measure KPI target H1 FY26
Bank
Operating profit
growth p.a. R400m R220m
FY29 profit ambition R3bn On
track
Life Life and Invest new
business IRR >RF+8% RF+8%
(16.8%)
Insure Margin c10% 15.2%
Discovery
SA
Earnings growth CAGR
(FY25-FY29) 12.5% - 17.5% p.a. 19%

-- 26 of 73 --

27
A full-service digital shared-value retail Bank
Key hypotheses
1 Using organic balance sheet growth. The analysis considers year-on-year growth in retail deposits: adjusting for the impact of any mergers or acquisitions, retail advances: credit cards (excl. overdrafts) and home loans. It does not consider other factors such as profitability, customer
experience and operational scale. Based on Dec 2025 BA900s
Fastest growing1 retail Bank in South
Africa with market-leading
digital capabilities	Shared-value banking
model1 |
Full retail banking
product suite2 |
Digital-first with
advanced AI capabilities3 | #1
Bank brand
# 1
Retail and private
banking service
Jul-21 Jan-26

-- 27 of 73 --

28
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Accounts Clients
Discovery Bank
Deposits Revenue (NII+NIR) Profit
+28% +21% +>100%	+34%
to 1.4m to R25.7bn to R75m	to R1.5bn
Gross retail
Advances
+42%
to R11.1bn
Total
accounts
Total
clients
+29%
to 3.4m
NII includes the allocation of interest earned on Treasury Bills (recognised at fair value gains in the income statement)
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
NII NIR
H1 2020	
H1 2021	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026

-- 28 of 73 --

29
Sales growth scaling efficiently
1 New business from clients who do not have any qualifying Discovery products (Discovery Health, Invest, Insure, Vitality, Gap and Life)
Daily sales Acquisition costs Sales mix
0
200
400
600
800
1 000
1 200
1 400
1 600
Jul-21	
Oct-21	
Jan-22	
Apr-22	
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23	
Jan-24	
Apr-24	
Jul-24	
Oct-24	
Jan-25	
Apr-25	
Jul-25	
Oct-25	
Jan-26
 0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
H1 2024
H1 2025
H1 2026
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Jan-24	
Apr-24	
Jul-24	
Oct-24	
Jan-25	
Apr-25	
Jul-25	
Oct-25
New to Discovery
Existing Discovery client
Average sales per workday
(calendar month)
Acquisition costs pcpm
baselined to H1 2024
New business by number of
existing Discovery products
Product mix
New business by product mix
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
H1 2022	
H2 2022	
H1 2023	
H2 2023	
H1 2024	
H2 2024	
H1 2025	
H2 2025	
H1 2026
TRX Bundled, Credit and Suite
Savings and TRX PAYT
1

-- 29 of 73 --

30
Balance sheet growth with improving credit quality
HL: Homeloans, PL: Personal loans; RCF: Revolving Credit Facility
Deposits Gross retail advances Impairments per client
0
5 000
10 000
15 000
20 000
25 000
30 000
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
 
-5
5
15
25
35
45
55
65
75
85
H1 2022	
H2 2022	
H1 2023	
H2 2023	
H1 2024	
H2 2024	
H1 2025	
H2 2025	
H1 2026
Average NII pcpm
Average Impairments pcpm
0
2 000
4 000
6 000
8 000
10 000
12 000
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
HL PL & RCF CC & DTA overdraft
11 051
Impairment pcpm vs NII pcpm (R)	(Rm) (Rm)

-- 30 of 73 --

31
Increasing engagement levels driving NIR growth
Spend1 NIR per client
NIR per client by
duration2
1 Restricted on active clients; 2 Standardising for current new business mix (0-3 months) sold in H1 2026 and baselined to duration 0-3 months
Engagement
576k
Flights booked
5.56bn
Miles earned
7.8m
Baskets earning
HealthyFood rewards
During H1 FY26 Spend pcpm baselined to
H1 2022
Baselined NIR pcpm
0
20
40
60
80
100
120
140
160
3	
6	
12
24-60
>60
Months on Bank
NIR pcpm before NBAC
0
20
40
60
80
100
120
140
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
0%
20%
40%
60%
80%
100%
120%
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026

-- 31 of 73 --

32
Scalability gains driving operational margin expansion
Profitability	=	Client growth x Revenue pc Expenses pc Impairments pc	- -	{ }
At 2-2.5m clients, operating profit → R3bn and 𝜶 = 𝑪𝒐𝒔𝒕
𝑰𝒏𝒄𝒐𝒎𝒆 → 40-50%
336
255
204
166
144
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Expenses pcpm
(R)
(excl. NBAC)
( 408.0)
( 266.7)
( 154.0)
69.2
318.9
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Profit Before NBAC
(Rm)
64 80 79 78 77
89
101 109 115 122
0
20
40
60
80
100
120
140
160
180
200
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Revenue pcpm (R)
(excl. NBAC)
NII pcpm NIR pcpm 19
14
18
16 16
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Impairments
pcpm (R)
0.39
0.58
0.83
1.09
1.40
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Clients (millions)

-- 32 of 73 --

33
Discovery Bank as the composite-maker
Key hypotheses
1 Using organic balance sheet growth. The analysis considers year-on-year growth in retail deposits: adjusting for the impact of any mergers or acquisitions, retail advances: credit cards (excl overdrafts) and home loans. It does not consider other factors such as profitability, customer
experience and operational scale. Based on Dec 2025 BA900s
Fastest growing1 retail
Bank in South Africa
with market-leading
digital capabilities
Shared-value banking
model1 |
Full retail banking
product suite2 |
Digital-first with
advanced AI capabilities3 |
Operating system of the
composite4 |

-- 33 of 73 --

34
Discovery Bank as the composite-maker
Enablers Value drivers
Consistent business
model and architecture
Data and AI
Unique Bank capabilities
*Assumes 30% of Bank app leads would have been received organically via other channels had Bank app enhancements not been done
Acquisition
and
origination*
Security
Functionality
Service
Shared
value and
rewards
In-app
calling
Clients
falling victim
to EFT fraud
(Indexed to
Oct-25)
100% 85% 87%
48% 20%
Oct-25
Nov-25
Dec-25
Jan-26
Feb-26
Health
leads
from
Bank
77%
Uplift vs
baseline
Life
leads
from
Bank
Insure
leads
from
Bank
127%
Uplift vs
baseline
98%
Uplift vs
baseline
In-App
Calling
Discovery 911
1
2
3 Payments	Security
Ecosystems
~9.5m
daily data
events

-- 34 of 73 --

35
Discovery Health
Figures are excluding Healthy Company in prior periods
Normalised profit New business Non-scheme growth	Membership
+5% +16% 3.86m
to R2 128m to R5 454m Lives under
administration
>305k lives
20%
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
1993	
1996	
1999	
2002	
2005	
2008
2011	
2014	
2017	
2020	
2023	
2025
Non Scheme Products
Restricted Schemes
DHMS
Jan-18	
Aug-18	
Mar-19	
Oct-19
May-20	
Dec-20
Jul-21
Feb-22	
Sep-22	
Apr-23	
Nov-23	
Jun-24	
Jan-25	
Aug-25
Flexicare
Gap cover
AHI
Includes R125m ATB
concession

-- 35 of 73 --

36
Actively addressing the issues of ageing and chronicity in the
Scheme
PHP: Personal Health Pathways; PHP engagement statistics as at 28 February 2026
Positive selection from Active Smart AI-driven behaviour change through PHP
January
2025
December
2025
Number of lives
4x
Fastest growing plan in the market
Active Smart
Chronic ratio
60% lower
than rest of
DHMS
Average age
6.4 years
younger than
rest of DHMS
1.39x 1.40x
1.55x
1.79x 1.86x
2.10x 2.10x
Prostate	
screening
Blood glucose
test
Cervical cancer
screening	
Colon cancer
screening
Mammogram
Flu vaccine
Foot screening
Completion rate relative to non-PHP members
575k
Activated lives
5.2m
Exercise actions
completed
67%
Of all actions are
completed by
chronic lives
887k
Health actions
completed

-- 36 of 73 --

37
Sustained growth and financial strength for DHMS
Customer satisfaction
and stability
Lower weighted
contribution increase Market share	Solvency
0%
1%
2%
3%
2021-22 2023-24 2025-26
Upgrades Downgrades
96%
5.5%
Members with no plan
changes
Lapse rate
0%
5%
10%
15%
20%
25%
30%
35%
40%
0
5
10
15
20
25
30
35
2021-22 2023-24 2025-26
Reserve
Actual Solvency
Required Solvency
R33.1 bn
32.6%
AAA
Projected unaudited
reserves
Projected unaudited
solvency
Credit rating
DHMS Rest of the
industry
Others
57.7% Market share
1 Effective contribution differential between DHMS and the next seven competitors; Effective contribution differential and increases take into account contribution deferrals
9.6% 9.3%
5.4%
10.8% 11.1%
10.1%
2024 2025 2026
DHMS
Next top 7 competitors
17.7% lower cost per unit benefit 1

-- 37 of 73 --

38
National Health Insurance (NHI) Act developments
Discovery’s position: NHI is not workable
without private sector collaboration NHI developments
Scheduled hearings on 5-7 May 2026 on the
constitutionality of Parliament’s public participation
process prior to the assent to the NHI Act
1. ConCourt process ongoing
Proclamation and/or implementation of any sections of the
NHI Act paused until the ConCourt delivers ruling
2. High Court order of 24 February 2026
Inflationary increase (3.3%) in medical scheme tax credits in
the 2026/27 budget with no structural changes
In the event of future amendments to tax credits, these
would likely only affect tax-payers earning more than R1m
p.a.
3. Medical Scheme Tax Credits

-- 38 of 73 --

39
Discovery Life
Normalised profit Cash generation New business
+15%
to R3 093m
Individual Life
-1%
to R1 635m
IFRS 17
Individual Life
Corporate & Employee Benefits (CEB)
+9%
Discovery Life Ltd
Cash flow before financing initiatives
and dividends to Group (Rbn)+6% New business APE (EV)
+16%
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
+16%
Leading market share - 2.4x the average of the next 5
largest writers in the underwritten retail risk business1
1. Market share source: NMG market report Q4 2025
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
1.5
1.6
0.6
1.1
0.8
New business API

-- 39 of 73 --

40
June 2025
New Business
Expected Unwind	
excl. new business
Experience	
Variances	
Economic	
Dividends
Other
December 2025
301
2 287 978
4 046
- 800 - 9
52 164
58 967
June 2025
ortality and morbidity
ium and fee income
Persistency
Policy alterations
Other
Total non-economic
Economic
Total
Positive operating variances, robust EV growth and improved
VNB margin
Positive operating variances Improved VNB margin Growth in Embedded Value
Individual Life:
3.8%
(IRR: RF +6.8%)
Life (excl. Invest) VNB margin (%)
Individual Life:
5.5%
(IRR: RF + 8%)
31.3% Annualised RoEV2
14.1% excl. economic updates
Discovery Life Ltd EV variances (Rm) Discovery Life Ltd EV growth (Rm)
389
1 080
1 Defined action plan being phased in to address policy alterations. Material componentsof it implemented with positive outcomes starting to be observed.
June 2025	
Economic
Business mix
Model changes
Other
December 2025
2.1%
4.3%
June 2025
December 2025
Premium & fee income
Persistency
Other
Total non
-economic	
Economic
Total
Policy alterations
1
Mortality & morbidity
December 2025
1 Defined action plan being phased in to address policy alterations. Material components of it implemented with positive outcomes starting to be observed; 2 Before dividend payments.
Economic assumptions
1 080
-111
58 968

-- 40 of 73 --

41
Tension between policy alterations and claims variances are
being actively managed
Positive operating variances (Rm)
Claims gain offsetting the
policy alterations strain
Mortality and morbidity
Premium and fee income
Persistency
Policy alterations
Other
Total non-economic
Economic
Total
389
1 080
Persistency
Premium & fee income
Other
Total non
-economic	
Economic
Total
Policy alterations
Mortality & morbidity
Shared-value model drives
continued risk improvements
Policy alterations variances
have remained a key priority
Increased Vitality health engagement in the
Discovery Life book
(API distribution)
Further improved experience observed for
engaged policyholders
(Mortality experience relative to expected)
Actions are being phased in – some lead
time until negative variance fully closed
Improvement observed in underlying lapses,
offsetting stress lapse assumption run-off
Blue Bronze Silver Gold Diamond
+15%
100%
None / Blue Bronze / Silver Gold / Diamond
-20%
-35%
H1
2023
H1
2026
H1
2023
H1
2026
H1
2023
H1
2026
H1
2023
H1
2026
H1
2023
H1
2026
+10%
H1
2025
H1
2026
H1
2025
H1
2026
H1
2025
H1
2026
Dec-25
observed
policy
alterations
and lapses
Impact of
actions
now live1
Interventions
under
development1
Indicative
policy
alterations
and lapses
net of
interventions
0
1 Estimated based on historic experience
Long-term claims experience observed at 93%

-- 41 of 73 --

42
Value generation of business under IFRS 17
CSM, RA and IFR increased over the period ZARm
23 251
34 084
7 395
3 053
1 046
- 382 -1 359
Store of value
June 2025:
CSM + RA +
OCI
New
Business
Insurance
finance
income/
expense
Non-financial
risk variances
and
basis changes
Release
to earnings
Store of value
December
2025:
CSM + RA +
OCI
= c47%
Growth from June 2025
OCI
RA
11 529
Includes
lapses, policy
alterations,
basis updates
CSM 1 081
1 166
1 430
497 3 093
CSM & RA
release
IFIE Other Life
segment
earnings
Components of Life
segment earnings
(incl. Premium Allocation Approach (PAA)
business such as Group Life)
Includes
claims
and NAV
variances
CSM = 23 507
RA = 7 877
IFR = -8 133
CSM = 24 103
RA = 10 509
IFR = -528
CSM = Contractual Service Margin; RA = Risk Adjustment; IFR = Insurance Finance Reserve; OCI = Other Comprehensive Income; IFIE = Insurance Finance Income or Expense
Store of value is calculated net of reinsurance but gross of tax
net of IFR
net of IFR ,
,

-- 42 of 73 --

43
Jul-21
Jan-22	
Jul-22	
Jan-23	
Jul-23
Jan-24	
Jul-24	
Jan-25	
Jul-25
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Discovery Invest
Normalised profit New business
Assets under
administration
+1% +13% +20%
to R984m to R1 961m to R200bn
+21%
Accounting for once-
off impacts
Once-off gains
Once-off losses
+1%

-- 43 of 73 --

44
Discovery Insure
Normalised profit Insurance revenue Operating margin	Gross new business
+34% +4% +24%	-2%
to R546m to R3 207m to R646m
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
to 15.2%
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026

-- 44 of 73 --

45
Vitality model compounds duration-driven outperformance
1 New Business based on policies with duration of less than 12 months during the period
Client quality improves
by duration
Lower accident frequency
by status and duration
Lapses improve by both
status and duration
0%
20%
40%
60%
80%
100%
Duration 1	
Duration 2	
Duration 3	
Duration 4	
Duration 5
Blue Bronze
Silver Gold
0%
20%
40%
60%
80%
100%
Blue
Bronze
Silver	
Gold
Diamond
Duration 1 Duration 5
Status distribution by duration Relative accident frequency by
status and duration
Relative lapse rate by status and
duration
0%
20%
40%
60%
80%
100%
Blue
Bronze
Silver	
Gold
Diamond
Duration 1 Duration 5
-71%
0%
20%
40%
60%
80%
100%
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Loss ratio of new business
continues to improve
New business1 loss ratio (rebased)
-28%

-- 45 of 73 --

46
Management initiatives and Vitality model drive loss ratio
improvements
Loss ratio shows sustained improvement
Full book loss ratio
Full book weather loss ratio
Full book non-weather loss ratio
10%
20%
30%
40%
50%
60%
70%
H1
2022
H1
2023
H1
2024
H1
2025
H1
2026
0%
5%
10%
15%
20%
H1
2022
H1
2023
H1
2024
H1
2025
H1
2026
0%
10%
20%
30%
40%
50%
60%
70%
H1
2022
H1
2023
H1
2024
H1
2025
H1
2026
-29%

-- 46 of 73 --

47
Vitality
Vitality Health	
International	
Vitality Network	
Vitality UK

-- 47 of 73 --

48
Unique macro contexts in key markets
United States
• Resilient GDP growth and inflation moderating with Treasury yields easing in Q3, with 10-year yields
drifting toward ~4% amid improved growth
• Wellness economy booming: $2.31tn (2025) → $3.70tn by 2034 (5.4% CAGR)
• Market volatility driven by regulatory unpredictability around vaccination policies, ACIP overhaul, and
FDA resignations (Moderna fell 11%, Novavax 6%, BioNTech 7%, and Pfizer 2%)
• In the second quarter of 2025, relative to the S&P 500, the US healthcare sector produced its worst
quarterly return in recent history (>20% decline in US healthcare valuations vs rest of S&P 500)
United Kingdom
• Stabilising but subdued growth
• Gilt yields reached their highest levels in 25 years due to fiscal concerns and sticky inflation
• Increases in National Insurance contributions (from 13.8% to 15%) increasing labour costs and putting
pressure on SMEs
• NHS facing widening financial pressures, with a £2 billion deficit and substantial backlogs (~7.29 million)
China
• GDP growth slowing to 4.8% in Q3 2025, with broad slowdown across industrial production and services
• Persistent deflationary pressure due to weak consumer demand and excess capacity
• Stimulus measures ongoing but confidence remains fragile
• Late-October rally in the Shanghai Composite saw the index trading above 3 900 (up ~28% since April)
• Government supportive of health insurance growth and long-term care expansion; 15th Five-Year Plan to
widen coverage and gradually raise retirement age (2025–2030)
0%
2%
4%
6%
8%
10%
2021
2022
2023
2024
2025E	
2026F
GDP growth
0%
2%
4%
6%
8%
10%
2021
2022
2023
2024
2025E	
2026F
0%
2%
4%
6%
8%
10%
2021
2022
2023
2024
2025E	
2026F

-- 48 of 73 --

49
Disciplined execution and delivery against targets
Transforming global insurance through
shared value powered by Vitality AI
Vitality Health	
International	
Vitality Network	
Vitality UK
Measure KPI target H1 FY26
Vitality UK
Premium growth
(GBP) >10% 14%
Life new business
IRR >RF+5% RF+9% (13%)
Health gross margin c7.5% 11%
Vitality
Network
Revenue growth
(USD) c15% -12%
Operating margin c50% 21%
Vitality
Health
International
PAHI premium
growth above
market
>5% 9%
PAHI Preserving quality profit growth Achieved
VitalityHealth US
break-even FY27 On track
Vitality Earnings growth
CAGR (FY25-FY29) 20% - 30% p.a. 41%

-- 49 of 73 --

50
Vitality strategic focus areas
2 Develop Vitality UK into a best-in-class health and life insurer, and
a centre of excellence for global expansionVitality UK
Continue to scale while adjusting to the change in Ping An Life
distribution	5 Ping An Health
Insurance
3 Restructure existing partnerships for maximum impact and
growth, and rapidly pursue new partnerships in Europe
Vitality
Network
4 Scale VitalityHealth US and Amplify Health in Asia, and ensure
they are profitable
Vitality Health
International
1 Develop and launch Vitality AI with Google into a single unique
capabilityVitality AI

-- 50 of 73 --

51
Vitality AI | Google – A defining global launch

-- 51 of 73 --

52
Vitality AI | Google – Amassed a rich and comprehensive
dataset that allows us to extract unique insights
Consolidated
on a single
platform
containing
over 60 million
life years (2 800
dimensions)
of behavioural-
linked insurance
data spanning
30 years
Incentives
Demography
Operational
Device
data
Clinical

-- 52 of 73 --

53
Vitality AI | Google – Harnessing data and AI to unlock
behavioural precision and engagement at scale
Combining Google’s secure, scalable cloud and AI capabilities with Vitality’s unique data
assets, AI and actuarial models, and leadership in incentivised behaviour change and
shared value to deliver precise and personalised health improvement actions at scale

-- 53 of 73 --

54
Vitality AI | Google – Offering the right incentive, at the
right moment, in a personalised manner
Global Partner Network
An integrated
incentive and
personalised
communication
framework to
reinforce
engagement
loops and
sustain long-
term behaviour
change
Personalised communication
Personalised using LLMs, generative AI,
entity profiles and indices to optimise
content and infrastructure

-- 54 of 73 --

55
Vitality AI | Google – Impact on behaviour and risk has
been recognised by leading reinsurers
Global Shared-Value
Reinsurance Panel
A library of
dynamic
pricing models
and heuristics,
with price
optimisation
across all
relevant areas,
underpinned
by an exclusive
reinsurance
panel
Personalised mortality curves
and dynamic pricing models
Healthy Gear
Inclusion of Vitality rating factor
within reinsurance agreements
Upfront selection discounts
in reinsurance rates, recognising
the positive selection associated
with Vitality-engaged clients
Additional behaviour
change discounts
automatically released to
insurers if the distribution of
policyholders’ physical activity
levels improve
Deep understanding of how mortality
changes based on behaviour
Age
Mortality
Premium
Policy term
Dynamic pricing of controllable
risk through policy term

-- 55 of 73 --

56
Vitality AI | Google – Manifesting in a seamless and
intuitive customer experience
Core lifestyle
behaviours
Physical activity
Sleep
Priority actions
High-risk
management

-- 56 of 73 --

57
Vitality UK
Normalised operating profit of VitalityHealth and VitalityLife
Normalised profit Premium income Lives covered	New business
+65% +14% +7%	+20%
to £66.0m to £698.5m to 2.02m	to £126.0m
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
GBP millions
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
GBP millions
IFRS 17

-- 57 of 73 --

58
VitalityHealth
Normalised profit Insurance revenue Lives covered	New business API
+97% +14% +2%	+8%
to £50.9m to £450.8m to 1.06m	to £61.8m
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
GBP millions	
GBP millions	
GBP millions
IFRS 17

-- 58 of 73 --

59
Operating margin
H1	
H2
H1	
H2
H1	
H2
H1	
H2
H1	
H2
H1
H2*
FY21 FY22 FY23 FY24 FY25 FY26*
Half-year margin
Full-year margin
7.5% margin
Higher margins in H1 driven by
normal claims seasonality
*Forecast
Margin recovery enabled by shared value dynamics and
stabilising claims environment
Premiums vs claims PLPM
(indexed to 2023)
Premiums rebased to
match increased claims
Continued recovery of
margins
95%
100%
105%
110%
115%
120%
125%
130%
Dec-22	
Mar-23	
Jun-23	
Sep-23	
Dec-23	
Mar-24	
Jun-24	
Sep-24	
Dec-24	
Mar-25	
Jun-25	
Sep-25	
Dec-25
Premiums
Claims (rolling 6m)
Selective retention of
healthier lives
Policy lapse rate and claims
relativity by status
(indexed to overall rate)
0%
20%
40%
60%
80%
100%
120%
Bronze
Silver
Gold
Platinum
Individual lapse rate
SME lapse rate
Overall
rate
Claims relativity by Vitality status1
(after normalising for other claims
factors)
Impact of increased
engagement on claims
7.5%
1.00
0.84 0.81
0.72
Bronze
Silver	
Gold
Platinum
1. GLMs were used to adjust for key risk factors (e.g. age, location, product mix, duration, underwriting type, sales channel), isolating the relative impact of individual factors by holding others constant
FY26
FY26 margin
is expected to
be above 7.5%

-- 59 of 73 --

60
VitalityLife
Normalised profit Premium income Lives covered	New business
+7% +14% +12%	+35%
to £15.1m to £247.7m to 958k lives	to £64.2m
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
IFRS 17
GBP millions	
GBP millions	
GBP millions

-- 60 of 73 --

61
Significant new business value and margin growth
enabled by Shared-value Insurance Model
VLUK new business market share1
Significant increase in
new business traction
Optimiser drives
improvement in mortality
Sales growth +
efficiencies driving value
Mortality by status
(Jul 22 - Dec 25, plans with Optimiser,
indexed to Bronze)
Lapse rate by status
(12m to Dec 25, indexed to Bronze)
Increased engagement
leads to greater retention
New business net value (£m)
(CSM & RA, less onerous new business)
-0.2
24.3
34.6
Bronze Silver Gold Platinum Bronze Silver Gold Platinum
47%	47%
1. Gen Re Protection Pulse
7.4%
10.1% 10.5%
12.4%
14.8%
Up to 50% in 24 months
Advisers writing:
44% more additional
covers selected
10% greater average
benefit size
Mix improvements with Optimiser:
H1 2024 H1 2025 H1 2026
H1 2024
H1 2025
H1 2026	
H1 2023	
H1 2022

-- 61 of 73 --

62
Value generation of business under IFRS 17
CSM, RA and IFR increased over the period GBPm
CSM = Contractual Service Margin; RA = Risk Adjustment; IFR = Insurance Finance Reserve; OCI = Other Comprehensive Income; IFIE = Insurance Finance Income or Expense
Store of value is calculated net of reinsurance but gross of tax
The new business margins generated of £37.3m excludes the impact of new reinsurance contracts attaching to the in-force book in the period. The total CSM and RA on new contracts incepted in the period was £29.5m. The difference is included in "Non-financial risk, variance, basis changes and other"
552.2
600.8
4.2
6.9
Store of value
June 2025: CSM +
RA + OCI
New business Insurance finance
income/expense2
Non-financial risk
variances, basis
changes and
other
Release to
earnings
Store of value
December 2025:
CSM + RA + OCI
= 9%
Growth from June 2025
OCI
CSM+RA
-20.3
11.1
20.5
37.3
,	RA, net of IFR net
of IFR

-- 62 of 73 --

63
Vitality Network
Integrated API by
insurance partners Revenue
Insurance partners
membership	Normalised profit
+13%
to $1 026m
-12%
to $48m
-46%
to $10.2m
+11%
to 6.9m
USD millions	
USD millions
USD millions
Macroeconomic gains Macroeconomic losses
+2%
accounting for
macro impacts
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
+7%
accounting for
macro impacts
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026

-- 63 of 73 --

64
The model has been successful for our partners
Integrated insurance premium1	Integrated API	Integrated API
H1
2023
H1
2024
H1
2025
H1
2026
H1
2023
H1
2024
H1
2025
H1
2026
H1
2023
H1
2024
H1
2025
H1
2026
+23% +10% +14%
1 Integrated Insurance Premium represents the cumulative in-force members annualised net premium

-- 64 of 73 --

65
• Unveiled to key stakeholders in London in November 2025
• Included announcement of strategic partnership with Google, introduction of panel of
shared-Value reinsurance partners, and several new Vitality Programme partners
Launched
Vitality AI
1
• An amicable end to the Generali partnership has opened up the European insurance
market. On the back of the success of shared-value insurance and the Vitality AI launch,
we are actively building a new carrier network across Europe
Growing
opportunities in
Europe
4
• Rebased SLI revenue assessment, making the revenue stream more consistent and
predictable
• Collectively committed to driving growth in SLI, to reach goal of 5m lives by 2030
Capitalising on
emergence of
value in SLI
2
• Accelerating shared-value insurance and Vitality AI product rollout in key AIA markets via
investment alongside AIA
Investing in
AIA Vitality
partnership
3
• The largest life insurance market in the world remains a strategic opportunity for growth
together with John Hancock and other non-competing carriers
Driving growth
in North
America
5
Considerable progress in positioning the business for
scale and growth

-- 65 of 73 --

66
Enhanced SLI commercial terms have created a large,
Yen-denominated asset for the Group
Yen and interest rate
movements
Asset value at Dec-25
USDm
Fixed revenue recognition1
-9%
change in JPY/USD
from Jun-25 to Dec-25
63bpsincrease in Japanese risk-free
rate from Jun-25 to Dec-25
1 Under the revised terms, VGI earns a fixed proportion of Gross Written Premium . The indicative fixed revenue recognition represents the expected value of this fixed proportion should new business, FX and risk-free rate assumptions hold
SLI = Sumitomo Life Insurance
$62m
Before macro
impacts
Accounting value
-9%
Calculated using a discount rate of risk-
free + 10%
2026	
2027	
2028	
2029	
2030	
2031
2032
2033
2034	
2035
2036	
2037	
2038
Recognition of new tranches
Unwind of tranches

-- 66 of 73 --

67
Vitality Health International
Note: Quantium Health, which is part of VHI, has not been included in this update ; WSH = WellSpark
1 Successful acquisition of WellSpark, including valuable contract
with EmblemHealth, with the migration of >1m members onto the
Vitality AI platform
2 Strong momentum in US health-plan sales – a key strategic
segment – adding 2.5m members from 1 January 2026
3 Rollout of Vitality AI, coaching and clinical programmes across all the
new health plan and employer clients from 1 January 2026
Ongoing rollout of scalable, AI-enabled and data-driven solutions
across Asia-Pacific, including an integrated product package with
multi-year value-share economics in four key markets
1
Three prestigious awards received for advancing health technology
services in Asia Pacific	2
Excellent performance, driven by robust operating margins together
with a substantial, once-off increase in investment returns	1
Transitioning distribution towards greater reliance on own channels,
with a focus on expanding and diversifying the mix of channels	2
Membership count (‘m)
-
1.0
2.0
3.0
4.0
Dec-22 Dec-23 Dec-24 Dec-25 Jan-26
Agency Health Plans
WSH WSH Health Plan
Employers

-- 67 of 73 --

68
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
Ping An Health Insurance
PAHI’s operating
results pre-tax
Discovery’s operating
result after tax
PAHI licence
new business1
PAHI licence
earned premium1
+59% +38% +8%
to RMB1.4bn
(RMB361m DSY’s share)
to RMB235m to RMB1.9bn
Lives
+17%
to 34.1m PAHI
licence lives
1 100% of PAHI
RMB millions	
RMB millions	
RMB millions	
RMB millions
+123%
before
investment
income
Jun-19	
Jun-20	
Jun-21	
Jun-22	
Jun-23	
Jun-24	
Jun-25	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026	
H1 2022	
H1 2023	
H1 2024	
H1 2025	
H1 2026
27% growth
in investment
income and
gains
+15%
to RMB9.5bn
Investment income and gains
Profit before investment
income and gains

-- 68 of 73 --

69
Transitioning distribution towards greater reliance on
own channels
Superior operational performance
New business split (%)
Growing non-PAL new business Broader growth strategy
Focusing on
expanding and
diversifying the
mix of distribution
channels
YoY change
in SuiShenYi
new business
+60% Positioning
SuiShenYi as the
primary engine
for long-term
growth
YoY change
in online new
business
+159% Expanding online
distribution and
capitalising on
growth in online
channels
Net profit margin
-4%
-2%
0%
2%
4%
6%
8%
10%
12%
14%
2019 2020 2021 2022 2023 2024 2025
H1 2024
H1 2025
H1 2026
Other PAL eShengBao

-- 69 of 73 --

70
Performance overview
Normalised
profit
+24%
to R8 891m
Headline
earnings
+29%
to R5 692m
Normalised
headline earnings
+27%
to R5 745m
Dividend
+28%
to 111 cps
New
business
+12%
to R14 026m

-- 70 of 73 --

71
Summary

-- 71 of 73 --

72
Presentation disclaimer
This presentation may contain forward looking statements with respect to certain of
Discovery’s plans and its current goals and expectations relating to its future performance
and results. All forward looking statements involve risk and uncertainty because they relate
to future events and circumstances which are beyond Discovery’s control. Accordingly,
Discovery’s actual future financial performance and results may differ. Any reference to
future financial performance has not been reviewed or reported on by the Group’s auditors.

-- 72 of 73 --

Unaudited
Interim Results
for the six months ended 31 December 2025

-- 73 of 73 --